Based on cytogenetic, genetic and epigenetic alterations found in MDS-BM, MDS phenotypes are considered to arise from impaired maturation and differentiation of CD34+CD38− hematopoietic stem cells (HSCs) [10–17]. Here, CD34 is linked to myelodysplastic syndrome.